Table 3

HLA genotypes in patients with CPI-induced diabetes and in patients treated with CPIs who did not develop diabetes

HLA genotypePatients, n/N (%)
Patients with diabetesA*02:01 (A2)13/22 (59)
DR177/17 (41.1)
DR73/17 (17.6)
DR116/17 (35)
DR121/17 (5.8)
DR36/17 (35)
DR416/21 (76)
Patients without diabetesA*02:01 (A2)5/9 (56)
DR31/9 (11)
DR42/9 (22)
  • n/N, positive/total N of patients checked.